Publications
5674 Results
- Journal / Conference
- Journal of Clinical Oncology Aug 1;39(22):2486-2496; May 14;JCO2100286. doi: 10.1200/JCO.21.00286. Online ahead of print
- Year
- 2021
- Research Committee(s)
- Genitourinary
- PMID
- PMID33989025
- Study Number(s)
- CTSU/C90601
Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance)
- Journal / Conference
- Annals of Oncology, Oct;32(10):1267-1275
- Year
- 2021
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID34293461
- PMC
- PMC8719434
- Study Number(s)
- CTSU/C80702
Combining tumor deposits with the number of lymph node metastases to improve the prognostic accuracy in stage III colon cancer: a post hoc analysis of the CALGB/SWOG 80702 phase III study (Alliance)
- Journal / Conference
- JCO Oncology Practice Jul;17(7):e908-e916; Apr 26;OP2000990. doi: 10.1200/OP.20.00990. Online ahead of print
- Year
- 2021
- PMID
- PMID33900801
- PMC
- PMC8462669
Hope, Burnout, and Life Satisfaction: An Intriguing Trinity Among Investigators of the SWOG Cancer Research Network
- Journal / Conference
- J Clin Oncol 39, 2021 (suppl 6; abstr 428) (ASCO GU Cancers Symposium (Feb 13-15, 2021 virtual), poster)
- Year
- 2021
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S1806
INTACT (S/N1806): Phase III Randomized Trial of Concurrent Chemoradiotherapy with or without Atezolizumab in Localized Muscle Invasive Bladder Cancer. Toxicity update on first 73 patients
- Journal / Conference
- J Clin Oncol 39, 2021 (suppl 15; abstr 4541) (American Society of Clinical Oncology Annual Meeting 2021, poster session)
- Year
- 2021
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S1605
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer: SWOG S1605 (NCT #02844816)
- Journal / Conference
- J Clin Oncol 39, 2021 (suppl 15; abstr 4131) (American Society of Clinical Oncology Annual Meeting 2021, poster session)
- Year
- 2021
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S1505
Body Composition Measurements and Overall Survival in Patients with Resectable Pancreatic Adenocarcinoma (SWOG Study S1505)
- Journal / Conference
- J Clin Oncol 39, 2021 (suppl 15; abstr 4104) (American Society of Clinical Oncology Annual Meeting 2021, poster session)
- Year
- 2021
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S0809
Does Adjuvant Chemoradiation Benefit Patients with Lymph Node Positive Biliary Tract Cancers? : A Secondary Analysis of SWOG S0809
- Journal / Conference
- J Clin Oncol 39, 2021 (suppl 15; abstr 9075) (American Society of Clinical Oncology Annual Meeting 2021, poster session)
- Year
- 2021
- Research Committee(s)
- Lung
- Study Number(s)
- S1800A
Phase II randomized study of ramucirumab plus pembrolizumab versus standard of care for advanced non-small cell lung cancer—toxicity update (Lung-MAP non-matched sub-study S1800A)
- Journal / Conference
- J Clin Oncol 39, 2021 (suppl 15; abstr TPS7567) (American Society of Clinical Oncology Annual Meeting 2021 (TIPS), poster session)
- Year
- 2021
- Research Committee(s)
- Leukemia
- Study Number(s)
- S1925
Randomized, Phase III Study of Early Intervention with Venetoclax and Obinutuzumab versus Delayed Therapy with Venetoclax and Obinutuzumab in Newly Diagnosed Asymptomatic High-Risk Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (Cll/Sll): Evolve Cll/Sll Study (SWOG S1925; NCT#04269902)
- Journal / Conference
- J Clin Oncol 39, 2021 (suppl 15; abstr 9024) (American Society of Clinical Oncology Annual Meeting 2021, poster discussion session)
- Year
- 2021
- Research Committee(s)
- Lung
- Study Number(s)
- S1900A